CYP46A1 and breast cancer: Recently, we showed that somatic mutations in CYP46A1 and functionally related genes, as well as in a group of genes associated with progesterone receptor status, are associated with poor survival in early estrogen‐receptor (ER)‐positive BC patients of the luminal subtype [15].